Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma

BACKGROUND: The acyclic retinoid, peretinoin, has been shown to be effective for suppressing hepatocellular carcinoma (HCC) recurrence after definitive treatment in a small-scale randomized clinical trial. However, little has been documented about the mechanism by which peretinoin exerts its inhibit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Honda, Masao, Yamashita, Taro, Yamashita, Tatsuya, Arai, Kuniaki, Sakai, Yoshio, Sakai, Akito, Nakamura, Mikiko, Mizukoshi, Eishiro, Kaneko, Shuichi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3660229/
https://ncbi.nlm.nih.gov/pubmed/23587162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-191
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak